Breast Pathology Flashcards

1
Q

Define carcinoma

A

Malignant tumour of epithelial origin
A subtype of carcinoma depends on the organ or tissue of origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define sarcoma

A

Malignant tumour arising from mesenchymal tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define lymphoma

A

Malignancy arising in lymphoid tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define leukaemia

A

Malignancy arising from haematopoietic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define malignant melanoma

A

Malignant tumour of melanocyte origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an excision biospy

A

Excise the area of abnormality with clear margins
Different to a diagnostic biospy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is an adenocarcinoma?

A

Gland forming/mucin producing tumour
GIT, Breast, endometrium, prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the relationship between ducts and lobules in the mammillary breast?

A

Progressively branching ducts leads to terminal ductular lobular units
Terminal ducts branch into lobules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the normal breast histology

A

Grape like clusters of acini = lobules
Lobules connect into ducts -> more tube-like in structure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the epithelium like in normal breast histology?

A

Luminal epithelial cells
Overly myoepithelial cells on basement membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the key benign pathologies of the breast?

A
  1. Epithelial hyperplasia - neoplasia (inc cell mass)
  2. Papilloma - wart like growth in milk ducts
  3. Fibroadenoma - neoplastic stromal cells and reactive epithelium
  4. Hemangioma - of blood vessels
  5. Fibrocystic disease -
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the different malignant pathologies can commonly affect the breast?

A
  1. Ductal/lobular carcinoma in situ
  2. Invasive ductal/lobular carcinoma
  3. Phyllodes tumour - malignant counterpart of fibroadenoma - stromal.
  4. Angiosarcoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the key feature of an in situ carcinoma?

A

Not invaded/breached the basement membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the key inflammatory breast diseases?

A

Breast abscess/mastitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the key pathological features of a breast abscess?

A

Usually an infection acquired during breast feeding
Staphylococcus aureus from skin
Formation of a lacatation abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the recommended treatment for a breast abscess?

A

Treated with antibiotics, continued expression of milk
Rarely - incision and drainage (can cause misshapen breast)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the key histopathological features of fibrocystic breast changes?

A

Dilated and cystic ducts (large hollow spaces)- lined by single epithelium
Prominent apocrine metaplasia - outgrowths into ducts
No cytological atypia or mitoses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the key history of fibrocystic breast disease?

A

Most common benign breast disease
Common in 30-5oyrs
Benign cystic typically mobile and rubbery on examination
Prone to hormonal alteration
Skin - dimpled or orange appearance, lumpy, thickened

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Do fibrocystic changes inc risk of breast cancer?

A

Not associated with an increased risk of malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the relevant histopathology of a fibroadenoma?

A

Growth of stroma compressing nearby glandular structures
No stromal atypica
Intact myoepithelial cell layer
Well defined/circumsided edge surrounded by background normal breast tissue

21
Q

What is the relevant history of a fibroadenoma disease?

A

Most common benign tumour of the female breast
Round, smooth, firm, mobile singular mass
Can occur at any age, most commonly 25yrs

22
Q

What is the key pathology underpinning a fibroadenoma?

A

Well-circumscribed, unencapsulated
Biphasic tumour - proliferation of glandular and stromal elements
No risk of malignancy

23
Q

What is the typical treatment for a fibroadenoma?

A

mage risk factors, patient preference
Conservative - follow up
Local surgical excision

24
Q

What are the key risk factors for breast carcinoma?

A

Age = 75% greater than 50yrs old
FH = up to 10% germline mutation in BRCA1/2
Reproductive history - early menarche, nulliparity, absence of breast feeding
Geographic = Europe and N America (diet, reproductive patterns and attitudes to breast feeding)

25
Q

What is the most common categoriy of breast malignancy?

A

Adenocarcinoma

26
Q

What is the difference between the in situ and invasive carcinoma stage of breast pathology?

A

In situ - neoplastic proliferation limited to ducts and lobules by basement membrane
Invasive - penetrated the BM into stroma - potential for lymphovascular invasion and metastatic spread

27
Q

What are the key features of this close up look at normal breast pathology?

A

Single later of epithelial cells
Basement membrane - pink line underneath - still in tact

28
Q

What is the key difference between ductal and lobular carcinoma in situ?

A

Cell of origin - ducts v lobules
Ductal - in expression of e-cadherin, more likely to show calcification on mammography
Lobular - dec expression of e-cadherin, less likely to show calcification on mammography (can still be present)

29
Q

What are the key features of ductal carcinoma in situ of low grade histopathology?

A

Atypical epithelium proliferation into the ducts (commonly excludes lumen)
Intact basement membrane
Darker areas of calcification
Pink central areas of comedo necrosis

30
Q

What are the features of ductal cell carcinoma in situ in high grade histopathology?

A

Mitoses
Abnormal muclear features
Variation in nuclea shape and size
Overlapping nuclei or cramped appearance

31
Q

What is the key risk of DCIS breast disease?

A

Precursor for invasive carcinoma

32
Q

What is the most common histological classification of breast cancer?

A

Invasive ductal carcinoma (70-80%)

33
Q

What are the key pathological features of the pathology of invasive ductal cell carcinoma?

A

Penetrated though BM and invaded stroma
Can can lymphatic/vascular invasion and metastases
Is an adenocarcinoma - mucin producing

34
Q

How does invasive ductal carcinoma appear on mammography?

A

Radiodense mass

35
Q

What skin changes can indicated invasive ductal carcinoma of the beast?

A

If central - nipple retraction
Blocked lymphatics - peau d orange

36
Q

What are the gross histological features of ductal cell carcinoma of the breast?

A

Haphazard outline - not clear, projecting into nearby tissue
Haphazard malignant glands - infiltrating stroma - different shape and size
May also just have abnormal cells in stroma/adipose tisse as invades - single or indian files (lines of cells with large and darkened, circular nuclei)

37
Q

What is removed in a radical mastectomy?
What are the consequences of this?

A

mammary glands
Both pectoral muscles
Entire axillary lymphatic tissue
Causes - permanent disfigurement, shoulders caved, arm swelling (elephantiasis)

38
Q

What are the different treatment options that exist for breast cancer today?

A

Surgery - mastectomy, breast conserving (wide local excision)
SLN biopsy - followed by axillary LN if positive
Radiotherapy
Chemotherapt
Endocrine therapy - esotrgen antagonists
Tissue targeted therapy - anti ERBB2 trastuzumab

39
Q

Who is invited to the NHS Breast Screening Programme?

A

All women aged 50 to 70 yrs - regerested with a GP every 3 years

40
Q

What is the role of pathology in breast cancer?

A

Biospy diagnosis - confirming benign or malignant
Grade tumours - give prognostic value
Identifying surface receptors

41
Q

What factors contribute to breast cancer tumour grading by Bloom Richardon System?

A

Tubule Formation (score from 1 -3)
Nuclear Pleomorphism (1-3)
Mitotic Activity(1-3)

Combined 3-5 is grade 1 (well differentiated)
6-7 Grade 2 (moderately differentiated)
8-9 Grade 3 (poorly differentiated)

42
Q

For what treatments is hormone receptor status important in breast cancer?

A

Tamoxifen - must be ER or PGR positive
Traztuzumab - targets HER2

43
Q

How does the receptor status of the tumour affect its prognosis?

A

Triple negative - more liekly to reoccur early on peak 2 years after diagnosis, risk then decreases
HER2 positive - less risk, bipeak at 2 years and 7 years
Luminal - lowest overall risk, relatively constant with small peak at 3 years

NOT YEAR IMPORTANT

44
Q

What are the different methods of spread of an invasive carcinoma?
Why are these important?

A

Direct spread
Lymphocvascular space invasion
Metastasis - locoregional lymph nodes, distant metastasis

These are important prognostic factors

45
Q

What is the key lymphatic drainage of the breast?

A

Axillary up to 75/90%
Parasternal lymph nodes
Inferior phrenic lymph nodes

46
Q

What is the role of pathological sentinel lymph node biopsies?

A

Between one and 3 lymph nodes are sampled
Axillary lymph node only is sentinel are positive
If positive consider chemotherapy or radiotherapy alongside surgical treatment

47
Q

What are the TNM stages for breast cancer?

A

T
1 - less than2cm
2 - less than 5cm
3 - greater than 5cm
4 - skin or chest wall

N
1 - ipsilatareal moveable axillary LN
2 - i fixed axillary or internal mammary LN
3 - infraclavicular, supracilvacule LN

M
1 - distant metastasis

48
Q

What is the use of personalised medicine in breast pathology?

A

Oncotype DX - quantifies risk of breast cancer recurrence to give a recurrence score
Low score are unlikely to benefit from additional chemotherapy alongside required hormonal therapy